These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 84343

  • 21. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T, Yagita H, Hashimoto Y.
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [Abstract] [Full Text] [Related]

  • 22. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
    Speranskiĭ DL, Blokhina NG, Bykovskaia SN, Kupriianova TA.
    Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
    [Abstract] [Full Text] [Related]

  • 23. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells].
    Liu XK, Liu HB, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 25; 88(12):853-5. PubMed ID: 18756993
    [Abstract] [Full Text] [Related]

  • 24. The inhibition of N-acetyltransferase activity and gene expression in human bladder cancer cells (T24) by shikonin.
    Yeh CC, Wu LT, Lin SY, Li TM, Chung JG.
    In Vivo; 2004 Mar 25; 18(1):21-31. PubMed ID: 15011747
    [Abstract] [Full Text] [Related]

  • 25. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.
    Shemtov MM, Cheng DL, Kong L, Shu WP, Sassaroli M, Droller MJ, Liu BC.
    J Urol; 1995 Jul 25; 154(1):269-74. PubMed ID: 7776443
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y, Yoshida O.
    J Urol; 1991 May 25; 145(5):1082-7. PubMed ID: 2016797
    [Abstract] [Full Text] [Related]

  • 28. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 May 25; 416():1-482. PubMed ID: 12616295
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG.
    Natl Cancer Inst Monogr; 1978 Dec 25; (49):245-7. PubMed ID: 748778
    [Abstract] [Full Text] [Related]

  • 31. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Feb 25; 147(2):505-10. PubMed ID: 1732632
    [Abstract] [Full Text] [Related]

  • 32. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M, Fukushima S, Tatemoto Y, Yamada K, Yuba R, Mori M.
    Anticancer Res; 1989 Feb 25; 9(2):319-26. PubMed ID: 2751258
    [Abstract] [Full Text] [Related]

  • 33. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum.
    Bloom ET.
    Urol Res; 1977 Feb 25; 5(3):141-8. PubMed ID: 919114
    [Abstract] [Full Text] [Related]

  • 34. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls.
    Troye M, Hansson Y, Paulie S, Perlmann P, Blomgren H, Johansson B.
    Int J Cancer; 1980 Jan 15; 25(1):45-51. PubMed ID: 7399744
    [Abstract] [Full Text] [Related]

  • 35. Immunological characterization of cell lines establishing from malignant and normal human urothelium.
    Vilien M, Wolf H, Rasmussen F.
    Eur J Cancer (1965); 1981 Mar 15; 17(3):321-7. PubMed ID: 7262169
    [No Abstract] [Full Text] [Related]

  • 36. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
    Hansson Y, Vargas-Cortes M, Paulie S, Perlmann P.
    Cancer Immunol Immunother; 1988 Mar 15; 27(3):205-12. PubMed ID: 3263206
    [Abstract] [Full Text] [Related]

  • 37. Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24.
    Catalona WJ, Oldham RK, Herberman RB, Djeu JY, Cannon GB.
    J Urol; 1977 Aug 15; 118(2):254-7. PubMed ID: 330885
    [Abstract] [Full Text] [Related]

  • 38. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
    Moroz C, Madgar I, Twig S, Lindner A, Many M.
    Int J Cancer; 1982 Jun 15; 29(6):667-72. PubMed ID: 6980847
    [Abstract] [Full Text] [Related]

  • 39. A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity.
    Larsson A, Näslund I, Troye M.
    Cancer Immunol Immunother; 1982 Jun 15; 14(2):82-5. PubMed ID: 6965230
    [Abstract] [Full Text] [Related]

  • 40. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P, Troye M, Pape G, Blomgren H, Johansson B.
    Urol Res; 1978 Jun 15; 6(4):207-9. PubMed ID: 741533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.